# Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration

> **NCT02024269** · NA · WITHDRAWN · sponsor: **Bioheart, Inc.**

## Conditions studied

- Dry Macular Degeneration

## Interventions

- **BIOLOGICAL:** Adipose Derived Stem Cells

## Key facts

- **NCT ID:** NCT02024269
- **Lead sponsor:** Bioheart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024269, "Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02024269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*